VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: VLAD who wrote (18095)	1/24/1999 5:49:00 PM
From: Greg22	Read Replies (3) of 23519

Muse is a good treatment but... The reason I will continue to hold this stock, and accumulate, is not because of a few cents of earnings, but rather the R&D coming down the pipe. Yes, Alibra will improve upon Muse, but the gene therapy approach will be revolutionary. Gene therapy has the potential to capture a large portion of Viagra market share down the road. I would like to hear more about progress in gene therapy during CC. In my opinion,this would be the major reason for anyone new to this stock to buy it (not to mention it is also undervalued). IMO, whether Vivus makes .05,.25, or 1.25 does not compare to the potential revenues from gene therapy...Just IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next